Luigetti Marco, Fabrizi Gian Maria, Bisogni Giulia, Romano Angela, Taioli Federica, Ferrarini Moreno, Bernardo Daniela, Rossini Paolo Maria, Sabatelli Mario
Department of Geriatrics, Neurosciences, Head & Neck Surgery and Orthopedics, Institute of Neurology, Catholic University of the Sacred Heart, Rome, Italy.
Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
Clin Neurol Neurosurg. 2016 May;144:67-71. doi: 10.1016/j.clineuro.2016.03.007. Epub 2016 Mar 9.
CMT is a group of heterogeneous motor and sensory neuropathies divided into demyelinating (CMT1) and axonal forms (CMT2). Distal Hereditary Motor Neuropathy (dHMN) is a motor neuropathy/neuronopathy which resembles CMT. Final genetic diagnosis is poor in CMT2 and in dHMN when compared with CMT1. Our aim is to report clinical, neurophysiological and genetic findings in a cohort of patients with axonal inherited neuropathies.
We report clinical, neurophysiological and genetic findings from 45 patients with CMT2 or dHMN, coming from 39 unrelated families, observed in our Institute of Neurology over a 20-year period.
Clinical and electrophysiological examinations showed that 38 patients had CMT2 and 7 patients presented dHMN. Extensive genetic evaluation showed 6 mutations in MFN2, 4 mutations in HSPB1, 2 mutations in BSCL2, 3 mutations in GJB1, 1 mutation in MPZ.
Since next-generation sequencing will not be easily accessible, epidemiological data and clinical "phenotyping" remain the best strategy for clinicians to reach a correct genetic diagnosis in CMT2 and dHMN patients.
遗传性运动感觉神经病(CMT)是一组异质性的运动和感觉神经病变,分为脱髓鞘型(CMT1)和轴索性(CMT2)。远端遗传性运动神经病(dHMN)是一种与CMT相似的运动神经病/神经元病。与CMT1相比,CMT2和dHMN的最终基因诊断率较低。我们的目的是报告一组轴索性遗传性神经病患者的临床、神经生理学和遗传学研究结果。
我们报告了在我们神经病学研究所20年间观察到的45例CMT2或dHMN患者的临床、神经生理学和遗传学研究结果,这些患者来自39个无亲缘关系的家庭。
临床和电生理检查显示,38例患者患有CMT2,7例患者患有dHMN。广泛的基因评估显示,MFN2有6个突变,HSPB1有4个突变,BSCL2有2个突变,GJB1有3个突变,MPZ有1个突变。
由于下一代测序不易获得,流行病学数据和临床“表型分析”仍然是临床医生对CMT2和dHMN患者做出正确基因诊断的最佳策略。